Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Zuber MX, Simpson ER, Waterman MR (1986) Science 234: 1258-61 Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers. Guix M, Granja Nde M, Meszoely I, Adkins TB, Wieman BM, Frierson KE, Sanchez V, Sanders ME, Grau AM, Mayer IA, Pestano G, Shyr Y, Muthuswamy S, Calvo B, Krontiras H, Krop IE, Kelley MC, Arteaga CL (2008) J Clin Oncol 26: 897-906 Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome. Moeder CB, Giltnane JM, Harigopal M, Molinaro A, Robinson A, Gelmon K, Huntsman D, Camp RL, Rimm DL, American Society of Clinical Oncology, College of American Pathologists (2007) J Clin Oncol 25: 5418-25 Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ (2007) Cell Metab 5: 143-9 TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer. Bhola NE, Balko JM, Dugger TC, Kuba MG, Sánchez V, Sanders M, Stanford J, Cook RS, Arteaga CL (2013) J Clin Invest 123: 1348-58 Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Tranguch S, Cheung-Flynn J, Daikoku T, Prapapanich V, Cox MB, Xie H, Wang H, Das SK, Smith DF, Dey SK (2005) Proc Natl Acad Sci U S A 102: 14326-31 Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Barnes HJ, Arlotto MP, Waterman MR (1991) Proc Natl Acad Sci U S A 88: 5597-601 Uterine FK506-binding protein 52 (FKBP52)-peroxiredoxin-6 (PRDX6) signaling protects pregnancy from overt oxidative stress. Hirota Y, Acar N, Tranguch S, Burnum KE, Xie H, Kodama A, Osuga Y, Ustunel I, Friedman DB, Caprioli RM, Daikoku T, Dey SK (2010) Proc Natl Acad Sci U S A 107: 15577-82 Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Sinars CR, Cheung-Flynn J, Rimerman RA, Scammell JG, Smith DF, Clardy J (2003) Proc Natl Acad Sci U S A 100: 868-73 Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene. Cai Q, Gao YT, Wen W, Shu XO, Jin F, Smith JR, Zheng W (2003) Cancer Res 63: 5727-30 Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Bailey LR, Roodi N, Dupont WD, Parl FF (1998) Cancer Res 58: 5038-41 Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk. Cui Y, Deming-Halverson SL, Beeghly-Fadiel A, Lipworth L, Shrubsole MJ, Fair AM, Shu XO, Zheng W (2014) Clin Cancer Res 20: 1169-78 Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M (1989) J Clin Endocrinol Metab 68: 446-54 Ovarian steroids differentially modulate the gene expression of gonadotropin-releasing hormone neuronal subtypes in the ovariectomized cynomolgus monkey. Krajewski SJ, Abel TW, Voytko ML, Rance NE (2003) J Clin Endocrinol Metab 88: 655-62 Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget. Bruner-Tran KL, Zhang Z, Eisenberg E, Winneker RC, Osteen KG (2006) J Clin Endocrinol Metab 91: 1554-60 Proliferating human granulosa-lutein cells in long term monolayer culture: expression of aromatase, cholesterol side-chain cleavage, and 3 beta-hydroxysteroid dehydrogenase. McAllister JM, Mason JI, Byrd W, Trant JM, Waterman MR, Simpson ER (1990) J Clin Endocrinol Metab 71: 26-33 Progesterone 16 alpha-hydroxylase activity is catalyzed by human cytochrome P450 17 alpha-hydroxylase. Swart P, Swart AC, Waterman MR, Estabrook RW, Mason JI (1993) J Clin Endocrinol Metab 77: 98-102 Molecular signaling in uterine receptivity for implantation. Paria BC, Lim H, Das SK, Reese J, Dey SK (2000) Semin Cell Dev Biol 11: 67-76 Plasma sex steroid hormones and breast cancer risk in Chinese women. Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, Li BD, Zheng W (2003) Int J Cancer 105: 92-7 Associations of reproductive time events and intervals with breast cancer risk: a report from the Shanghai Breast Cancer Study. Huang Z, Beeghly-Fadiel A, Gao YT, Zheng Y, Dai Q, Lu W, Zheng W, Shu XO (2014) Int J Cancer 135: 186-95 The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status. Baglia ML, Zheng W, Li H, Yang G, Gao J, Gao YT, Shu XO (2016) Int J Cancer 139: 742-8 Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam EM, Inoue K (1999) Carcinogenesis 20: 1607-13 p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD, Parl FF (1994) Cancer 73: 2147-56 Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017. De Los Santos JF, Cantor A, Amos KD, Forero A, Golshan M, Horton JK, Hudis CA, Hylton NM, McGuire K, Meric-Bernstam F, Meszoely IM, Nanda R, Hwang ES (2013) Cancer 119: 1776-83 African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, Soler-Vila H, Beeghly A, Duan F, Owens P (2004) Cancer 101: 1293-301 Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort. Giltnane JM, Moeder CB, Camp RL, Rimm DL (2009) Cancer 115: 2400-9 Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population. Xu WH, Long JR, Zheng W, Ruan ZX, Cai Q, Cheng JR, Xiang YB, Shu XO (2009) Cancer 115: 2693-700 The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium. Rokicki J, Das PM, Giltnane JM, Wansbury O, Rimm DL, Howard BA, Jones FE (2010) Mol Cancer 9: 150 Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W (2001) Br J Cancer 85: 372-8 Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Anastassiadis K, Fu J, Patsch C, Hu S, Weidlich S, Duerschke K, Buchholz F, Edenhofer F, Stewart AF (2009) Dis Model Mech 2: 508-15 Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Bao PP, Shu XO, Gao YT, Zheng Y, Cai H, Deming SL, Ruan ZX, Su Y, Gu K, Lu W, Zheng W (2011) Am J Epidemiol 174: 661-71 Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Greenberg NM, Tilley WD (2001) Mol Endocrinol 15: 46-56 Regulation of the synthesis of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the bovine ovary in vivo and in vitro. Rodgers RJ, Mason JI, Waterman MR, Simpson ER (1987) Mol Endocrinol 1: 172-80 Levels of messenger ribonucleic acid encoding cholesterol side-chain cleavage cytochrome P-450, 17 alpha-hydroxylase cytochrome P-450, adrenodoxin, and low density lipoprotein receptor in bovine follicles and corpora lutea throughout the ovarian cycle. Rodgers RJ, Waterman MR, Simpson ER (1987) Mol Endocrinol 1: 274-9 Cholesterol side-chain cleavage cytochrome P450 gene expression in the primitive gut of the mouse embryo does not require steroidogenic factor 1. Keeney DS, Ikeda Y, Waterman MR, Parker KL (1995) Mol Endocrinol 9: 1091-8 Research Resource: Correlating Human Cytochrome P450 21A2 Crystal Structure and Phenotypes of Mutations in Congenital Adrenal Hyperplasia. Pallan PS, Lei L, Wang C, Waterman MR, Guengerich FP, Egli M (2015) Mol Endocrinol 29: 1375-84 Regulation of cholesterol side-chain cleavage and 17 alpha-hydroxylase/lyase activities in proliferating human theca interna cells in long term monolayer culture. McAllister JM, Kerin JF, Trant JM, Estabrook RW, Mason JI, Waterman MR, Simpson ER (1989) Endocrinology 125: 1959-66 Mammogenic hormones differentially modulate keratinocyte growth factor (KGF)-induced proliferation and KGF receptor expression in cultured mouse mammary gland epithelium. Pedchenko VK, Imagawa WT (1998) Endocrinology 139: 2519-26
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.